Investigating genetic factors in sickle cell disease and its complications
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
This study is looking at how certain genes might affect people with sickle cell disease and their risk of developing serious issues like blood cancers, so if you have sickle cell disease, your participation could help find better treatments tailored just for you!
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11062390 on NIH RePORTER |
What this research studies
This research focuses on understanding how genetic variations contribute to the complications of sickle cell disease (SCD), particularly the risk of developing acute myeloid leukemia and other serious conditions. By examining the genetic makeup of individuals with SCD, the researchers aim to identify mutations that may lead to clonal hematopoiesis, a condition that can predispose patients to blood cancers and organ damage. The study will involve analyzing blood samples and genetic data from participants to uncover these links and improve treatment strategies. Patients may be offered advanced therapies, including stem cell transplants, based on their genetic profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with sickle cell disease, particularly those experiencing complications related to heart, lung, or kidney function.
Not a fit: Patients without a diagnosis of sickle cell disease or those who do not exhibit complications related to the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-targeted treatments and improved outcomes for patients with sickle cell disease.
How similar studies have performed: Previous research has shown that understanding genetic mutations in blood disorders can lead to significant advancements in treatment, suggesting a promising avenue for this investigation.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Bick, Alexander — Vanderbilt University Medical Center
- Study coordinator: Bick, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.